Using ultrasound to guide endometrial biopsies for post-menopausal bleeding
Official title: Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding: Randomised Controlled Trial.
Run by Imperial College Healthcare NHS Trust · NCT06501846 · Data updated 2026-11-12
This study is testing if using ultrasound to guide endometrial biopsies can help women with post-menopausal bleeding get better tissue samples and avoid more invasive procedures.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 92 (estimated) |
| Sponsor | Imperial College Healthcare NHS Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | July 23, 2024 |
| Main results expected | July 23, 2027 |
| Study ends | July 23, 2027 |
| Registry record updated | July 15, 2024 |
| Trial ID | NCT06501846 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older who are experiencing post-menopausal bleeding and require an endometrial biopsy.
✕Probably not a fit
Patients with known focal endometrial pathology or a history of endometrial cancer or hyperplasia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effectiveness of using transabdominal ultrasound guidance during Pipelle® endometrial biopsies for women experiencing post-menopausal bleeding. The aim is to improve the success rate of obtaining adequate tissue samples for laboratory assessment, thereby reducing the need for more invasive procedures. Participants will be randomly assigned to receive either ultrasound-guided or standard biopsies. The study focuses on women with thickened endometrial linings who require biopsies to rule out endometrial cancer or hyperplasia.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate diagnoses and fewer invasive procedures for women with post-menopausal bleeding.
How similar studies have gone: Other studies have shown promise in using ultrasound guidance for biopsies, suggesting this approach may enhance diagnostic accuracy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with post-menopausal bleeding who require an endometrial biopsy. Further details: * Post-menopausal bleeding is defined as bleeding one year after a woman's last menstrual period or bleeding six months after starting continuous combined hormone replacement therapy. * There is no upper age limit, however all patients must be 18 or above. Strict ultrasound criteria will be followed: * Endometrium ≥5mm: this is the current cut off used by Imperial College Healthcare NHS Trust for a biopsy to be indicated in the context of post-menopausal bleeding. * Smooth, homogenous endometrium with a clearly defined border. Exclusion Criteria: * Focal endometrial pathology (including but not limited to endometrial polyps, type 0-2 fibroids, uterine septa and other uterine structural abnormalities). * Suspicion of non-benign myometrial pathology. * History of endometrial cancer or endometrial hyperplasia. * History of cervical cancer. * Virgo intacta. * Inability to tolerate vaginal examination. * Inability to consent. * The denial or withdrawal of informed written consent.
Where it's running
-
Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare Trust
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Joseph Yazbek, MD — Imperial College Healthcare Trust
- Study coordinator: Joseph Yazbek, MD
- Email: joseph.yazbek@nhs.net
- Phone: 02033133570
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking outcomes of uterine cavity conditions after hysteroscopy
This project will follow adults with endometrial polyps, hyperplasia, or cancer who undergo hysteroscopy to see if detailed clinical and pathology data can predict disease course over one year.
-
Fertility preservation for women with endometrial cancer and hyperplasia
This study is testing a new surgery to help younger women with early-stage endometrial cancer or hyperplasia keep their ability to have children instead of needing a hysterectomy.
-
Personalized navigation to support rural and Black women with endometrial cancer
This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.